Home Newsfeeds Jefferies Downgrades Harmony Biosciences to Hold, Announces $57 Price Target

Jefferies Downgrades Harmony Biosciences to Hold, Announces $57 Price Target

Jefferies analyst Chris Howerton downgrades Harmony Biosciences (NASDAQ:HRMY) from Buy to Hold and announces $57 price target.

byBenzinga Newsdesk

August 3, 2022

1 minute read

Jefferies analyst Chris Howerton downgrades Harmony Biosciences (NASDAQ:HRMY) from Buy to Hold and announces $57 price target.

News

Creative Medical Technology Holdings Announces Next Milestone Achievements In ImmCelz Platform Development; Advancements May Result In Ability To Treat A Broader Patient Population With Immune Disorders

By Benzinga Newsdesk

May 22, 8:43 AM

Advancements May Result in Ability to Treat a Broader Patient Population with Immune DisordersPHOENIX, May 22, 2023 /PRNewswire/ -- Creative Medical Technology Holdings, Inc. ("Creative Medical Technology" or the

CELZ

Here’s How Much $100 Invested In Southwest Airlines 10 Years Ago Would Be Worth Today

By Benzinga Insights

November 24, 12:33 PM

Southwest Airlines (NYSE:LUV) has outperformed the market over the past 10 years by 4.12% on an annualized basis…

LUV

News
Tech

How To Unlock Your iPhone Using iOS 17’s Neat Passcode Reset Trick

By Ananya Gairola

September 14, 9:56 AM

Apple's iOS 17 introduces a new feature allowing users to revert to their previous iPhone passcode within 72 hours of changing it, providing a solution for those who forget their new passcode.

AAPL

Jack Dorsey Reacts To Sam Altman’s Video Showing ‘Crazy Lines Around The World’ As Worldcoin Causes Frenzy For Iris Scans

By Mehab Qureshi

July 27, 12:48 AM

Worldcoin (CRYPTO: WLD), an ambitious project led by OpenAI co-founder Sam Altman, has ignited a diverse range of reactions within the technology and cryptocurrency communities, with Twitter co-founder Jack Dorsey being the latest to voice his concerns.

ETH

Jefferies Downgrades Harmony Biosciences to Hold, Announces $57 Price Target

Related Posts

Creative Medical Technology Holdings Announces Next Milestone Achievements In ImmCelz Platform Development; Advancements May Result In Ability To Treat A Broader Patient Population With Immune Disorders

Here’s How Much $100 Invested In Southwest Airlines 10 Years Ago Would Be Worth Today

How To Unlock Your iPhone Using iOS 17’s Neat Passcode Reset Trick

Jack Dorsey Reacts To Sam Altman’s Video Showing ‘Crazy Lines Around The World’ As Worldcoin Causes Frenzy For Iris Scans